S C Rastogi

Author PubWeight™ 47.49‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups. J Infect Dis 1983 6.15
2 Summary of clinical trials of influenza virus vaccines in adults. J Infect Dis 1977 2.29
3 Further studies on the immunogenicity of Haemophilus influenzae type b and pneumococcal type 6A polysaccharide-protein conjugates. Infect Immun 1983 2.10
4 The Vaccine Adverse Event Reporting System (VAERS). Vaccine 1994 2.02
5 Comparative immunogenicity of group 6 pneumococcal type 6A(6) and type 6B(26) capsular polysaccharides. Infect Immun 1979 1.61
6 Skull radiology in patients with psychiatric illness. Br Med J (Clin Res Ed) 1983 1.29
7 High prevalence of antibodies to the gp120 V3 region principal neutralizing determinant of HIV-1MN in sera from Africa and the Americas. AIDS Res Hum Retroviruses 1991 1.17
8 The processing and collaborative assay of a reference endotoxin. J Biol Stand 1983 1.14
9 Comparative trial of influenza vaccines. II. Adverse reactions in children and adults. Am J Epidemiol 1976 1.11
10 New developments in the measurement of the hemagglutinin content of influenza virus vaccines by single-radial-immunodiffusion. J Biol Stand 1980 1.06
11 Comparative trial of influenza vaccines. I. Immunogenicity of whole virus and split product vaccines in man. Am J Epidemiol 1976 0.99
12 Human immunodeficiency virus neutralizing antibodies in sera from North Americans and Africans. J Acquir Immune Defic Syndr 1990 0.97
13 Results of nationwide screening of blood and plasma for antibodies to human T-cell lymphotrophic III virus, type III. Transfusion 1986 0.95
14 Immunogenicity of wild and attenuated varicella-zoster virus strains in rhesus monkeys. J Med Virol 1984 0.94
15 Cross-immunogenicity of pneumococcal group 9 capsular polysaccharides in adult volunteers. Infect Immun 1982 0.93
16 Further important sensitizers in patients sensitive to fragrances. Contact Dermatitis 2002 0.88
17 Statistical determination of endotoxin content in influenza virus vaccine by the limulus amoebocyte lysate test. J Clin Microbiol 1977 0.86
18 A standardized quantitative skin-test assay of allergen potency and stability: studies on the allergen dose-response curve and effect of wheal, erythema, and patient selection on assay results. J Allergy Clin Immunol 1982 0.86
19 Quality control procedures for testing limulus amebocyte lysate sensitivity using Reference Endotoxin 1b. Bull Parenter Drug Assoc 1977 0.84
20 Lysosomal (leucocyte) proteinase and sulfatase levels in Dyggve-Melchior-Clausen (DMC) syndrome. Acta Neurol Scand 1977 0.84
21 Stimulation of active E-rosette forming lymphocytes by myelin basic protein and specific antigens from multiple sclerosis brains. J Neurol Sci 1979 0.83
22 Is hypoallergenic a credible term? Clin Exp Dermatol 2004 0.83
23 Electromyographic changes in automechanics with increased heavy metal levels. Acta Neurol Scand 1976 0.83
24 Heavy metal pollution among autoworkers. II. Cadmium, chromium, copper, manganese, and nickel. Br J Ind Med 1977 0.82
25 Heavy metal levels and delta-amino-levulinic acid dehydrase levels in peripheral polyneuropathy. Acta Neurol Scand 1976 0.82
26 Abnormal serum alpha 2-macroglobulin in Dyggve-Melchior-Clausen syndrome. J Clin Chem Clin Biochem 1980 0.81
27 The enhancing effect of multiple sclerosis brain homogenates on the active E-rosette forming lymphocytes in neurological disorders. Acta Neurol Scand 1979 0.80
28 The Dyggve-Melchior-Clausen (DMC) syndrome. A 15 year follow-up and a survey of the present clinical and chemical findings. Neuropadiatrie 1977 0.80
29 Content and reactivity to product perfumes in fragrance mix positive and negative eczema patients. A study of perfumes used in toiletries and skin-care products. Contact Dermatitis 1997 0.79
30 Selenium and lead: mutual detoxifying effects. Toxicology 1977 0.79
31 The enhancing effect of multiple sclerosis brain homogenates on the active E rosette forming lymphocytes. J Neurol 1978 0.79
32 A collaborative study to establish an International Standard Rabies immunoglobulin of human origin. J Biol Stand 1985 0.78
33 Statistical procedure for evaluating the sensitivity of Limulus amoebocyte lysate by using a reference lysate. Appl Environ Microbiol 1979 0.78
34 Further important sensitizers in patients sensitive to fragrances. Contact Dermatitis 2002 0.78
35 A neutralising monoclonal antibody against a paramyxovirus reacts with a brain antigen. J Neuroimmunol 1985 0.78
36 A collaborative study on the testing of rabies immune globulin (human) by the mouse neutralization test (MNT) and the rapid fluorescent focus inhibition test (RFFIT). J Biol Stand 1979 0.78
37 Partial purification of MS specific brain antigens. Acta Neurol Scand 1979 0.78
38 Membrane-bound 2',3',-cyclic nucleotide 3'-phosphohydrolase activity of lymphocytes, granulocytes and erythrocytes in multiple sclerosis. Acta Neurol Scand 1985 0.78
39 A simple method for the isolation of multiple sclerosis specific brain antigens. Clin Chim Acta 1980 0.78
40 Lyral is an important sensitizer in patients sensitive to fragrances. Br J Dermatol 1999 0.77
41 Contact allergy to popular perfumes; assessed by patch test, use test and chemical analysis. Br J Dermatol 1996 0.77
42 Deodorants: a clinical provocation study in fragrance-sensitive individuals. Contact Dermatitis 1998 0.77
43 Estimation of levels of IgG to multiple sclerosis specific brain antigens in the cerebrospinal fluid of MS patients. Neurochem Res 1983 0.77
44 Loss of lysosomal neutral proteinase from leucocytes induced by the action of multiple sclerosis-specific brain antigens. Clin Exp Immunol 1980 0.75
45 Abnormalities in native and dissociated alpha 2-macroglobulin isolated from multiple sclerosis serum. Clin Chim Acta 1980 0.75
46 The Allergen Bank: a source of extra contact allergens for the dermatologist in practice. Acta Derm Venereol 1996 0.75
47 Iodopropynyl butylcarbamate: a new contact allergen. Contact Dermatitis 1997 0.75
48 Standardization of factor IX: standards for "purified" factor IX concentrates. Thromb Haemost 1991 0.75
49 Exposure to selected fragrance materials. A case study of fragrance-mix-positive eczema patients. Contact Dermatitis 1996 0.75
50 Phospholipids from the seeds of Hibiscus abelmoschus. Planta Med 1969 0.75
51 Abnormal serum alpha 2-macroglobulin in multiple sclerosis. Eur Neurol 1981 0.75
52 Distribution of phospholipids in the various organs of Labeo rohita. Indian J Biochem 1970 0.75
53 Polychlorinated biphenyls and heavy metal levels in recycled paper for household use. Bull Environ Contam Toxicol 1988 0.75
54 Multiple sclerosis specific antigens in MS brains. Acta Neurol Scand 1978 0.75
55 Degradation of basic protein and Wolfgram protein in central nervous system by soluble enzymes of human peripheral polymorphonuclear leucocytes. J Neurol Sci 1981 0.75
56 In vitro IgG synthesis by peripheral blood lymphocytes of multiple sclerosis patients and normal individuals. Effect of multiple sclerosis and non-multiple sclerosis brain antigens. Eur Neurol 1983 0.75
57 Absorption of lead through the skin. Toxicology 1977 0.75
58 Allergic contact dermatitis from sodium dihydroxycetyl phosphate, a new cosmetic allergen? Contact Dermatitis 2001 0.75
59 The anatomy of the heart of the Indian sand lizard, Ophiomorus tridactylus Blyth. Anat Anz 1965 0.75
60 Kinetics of inhibition of mitogen-induced proliferation of human lymphocytes by alpha 2-macroglobulin in serum-free medium. Immunobiology 1985 0.75
61 Remoxipride and haloperidol in the acute phase of schizophrenia: a double-blind comparison. Acta Psychiatr Scand Suppl 1990 0.75
62 Contact sensitization to dipropylene glycol in an eczema population. Contact Dermatitis 1995 0.75
63 Identification of coumarin as the sensitizer in a patient sensitive to her own perfume but negative to the fragrance mix. Contact Dermatitis 1999 0.75
64 A study of trehalase (EC 3.2.1.28) and trehalose in relation to aging in Callosobruchus analis. Acta Physiol Hung 1985 0.75
65 Statistical procedure for standardizing control standard endotoxin against U.S. reference standard endotoxin using Limulus amebocyte lysate test. Prog Clin Biol Res 1982 0.75
66 Testing with fine fragrances in eczema patients: results and test methods. Contact Dermatitis 2001 0.75
67 Identification of Lilial as a fragrance sensitizer in a perfume by bioassay-guided chemical fractionation and structure-activity relationships. Contact Dermatitis 2000 0.75
68 [Formaldehyde in shampoos and creams]. Ugeskr Laeger 1993 0.75
69 Multiple sclerosis-specific central nervous system antigens (MSG2): a blind study. Eur Neurol 1983 0.75
70 Threshold responses in cinnamic-aldehyde-sensitive subjects: results and methodological aspects. Contact Dermatitis 1996 0.75
71 Co-dergocrine (hydergine) in the treatment of tardive dyskinesia. Psychol Med 1982 0.75
72 Standards for assay of von Willebrand factor concentrates: a collaborative study. Thromb Haemost 1993 0.75
73 Histochemical studies on the midgut and hepatic caeca of Periplaneta americana (L.). Z Mikrosk Anat Forsch 1972 0.75
74 Effect of multiple sclerosis alpha 2-macroglobulin on mitogen induction of lymphocyte proliferation. Immunobiology 1985 0.75
75 Allergic contact dermatitis from methyldibromo glutaronitrile--clinical cases from 2003. Contact Dermatitis 2005 0.75
76 In vitro stimulation of multiple sclerosis (MS) T and B lymphocytes by autologous monokines generated in the presence of MS-specific brain antigens. Clin Immunol Immunopathol 1982 0.75
77 Quantitation of multiple sclerosis specific central nervous system antigens in various regions of MS brains. Eur Neurol 1985 0.75
78 The Dyggve-Melchior-Clausen syndrome. Clin Chim Acta 1977 0.75
79 Effects of prostaglandins E1 and E2 on the de novo synthesis of lipids in human platelets & whole blood. Indian J Biochem Biophys 1977 0.75
80 Thymidine uptake by lymphocytes in the presence of supernatants of polymorphonuclear leucocytes incubated with multiple sclerosis brain antigens. Acta Neurol Scand 1983 0.75
81 Biochemical abnormalities in Dyggve-Melchior-Clausen syndrome. Clin Chim Acta 1978 0.75
82 Phospholipids from the seeds of Desmodium gangeticum. Planta Med 1971 0.75